The role of immunologic effector cells in the development of post-transplant lymphoproliferative disorders (PTLD).

被引：0
|
作者：
Shpilberg, O [1 ]
Wilson, J [1 ]
Green, M [1 ]
Nalesnik, M [1 ]
Day, R [1 ]
Herberman, RB [1 ]
Whiteside, T [1 ]
机构：
[1] UNIV PITTSBURGH,INST CANC,PITTSBURGH,PA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1354 / 1354
页数：1
相关论文
共 50 条
  • [41] Treatment for renal post-transplant lymphoproliferative disorder (PTLD) with rituximab
    Berthou, J.
    Nerich, V.
    Fagnoni-Legat, C.
    Bittard, H.
    Chalopin, J. M.
    Limat, S.
    PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1015 - 1015
  • [42] EBV-induced post-transplant lymphoproliferative disorder (PTLD)
    Birkeland, SA
    HamiltonDutoit, S
    Sandvej, K
    Andersen, HMK
    Bendtzen, K
    Moller, B
    Jorgensen, KA
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3467 - 3472
  • [43] Targeting Akt for Treatment of Post-Transplant Lymphoproliferative Disorder (PTLD)
    Hatton, O.
    Lambert, S.
    Krams, S. M.
    Esquivel, C. O.
    Martinez, O. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 137 - 137
  • [44] Management of post-transplant lymphoproliferative disorders
    Dierickx, Daan
    Vergote, Vibeke
    HEMASPHERE, 2019, 3 : 74 - 77
  • [45] Management of post-transplant lymphoproliferative disorders
    DeStefano, Christin B.
    Desai, Sanjal H.
    Shenoy, Aarthi G.
    Catlett, Joseph P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (03) : 330 - 343
  • [46] Management of post-transplant lymphoproliferative disorders
    Llaurador, Gabriela
    McLaughlin, Lauren
    Wistinghausen, Birte
    CURRENT OPINION IN PEDIATRICS, 2017, 29 (01) : 34 - 40
  • [47] Post-transplant lymphoproliferative disorders (PTLD): Long-term outcome and prognostic factors.
    Habermann, TM
    Ansell, SM
    Velosa, JA
    Wiesner, RH
    Sterioff, S
    Walker, RC
    Strickler, J
    Paya, CV
    McGregor, CGA
    BLOOD, 1999, 94 (10) : 513A - 513A
  • [48] CD-20 expression in post-transplant lymphoproliferative disorders(PTLD): Treatment with Rituximab.
    Ifthikharuddin, JJ
    Mieles, LA
    Rosenblatt, JD
    Ryan, CK
    Sahasrabudhe, DM
    BLOOD, 1999, 94 (10) : 248B - 248B
  • [49] Histogenesis of neoplastic B-cells in post-transplant lymphoproliferative disorders (PTLD) correlates with transplantation type and site of involvement
    Novoa-Takara, L
    Kampalath, B
    Vesole, DH
    Shidham, V
    Rao, A
    Chang, C
    MODERN PATHOLOGY, 2003, 16 (01) : 246A - 246A
  • [50] Histogenesis of neoplastic B-cells in post-transplant lymphoproliferative disorders (PTLD) correlates with transplantation type and site of involvement
    Novoa-Takara, L
    Kampalath, B
    Vesole, DH
    Shidham, V
    Rao, A
    Chang, C
    LABORATORY INVESTIGATION, 2003, 83 (01) : 246A - 246A
12345